The company’s state-of-the-art Iovance Cell Therapy Center (iCTC) in Philadelphia, a 136,000-square-foot manufacturing hub, was said to be back online without disruption. That narrative shifted ...

The company's state-of-the-art Iovance Cell Therapy Center (iCTC) in Philadelphia, a 136,000-square-foot manufacturing hub, was said to be back online without disruption. In the wake of these ...

Our Philadelphia-based manufacturing network consists of 2 FDA-approved facilities, our internal manufacturing facility, the Iovance Cell Therapy Center, or ICTC, and an American-owned contract ...

They recall a time when Philadelphia’s Navy Yard hummed with ... is currently home to commercial tenants, including Iovance Biotherapeutics, but residents will arrive this fall.

As part of an effort to increase its cell therapy manufacturing, Iovance Biotherapeutics is planning to add hundreds of new jobs at its manufacturing site at the Philadelphia Navy Yard, writes John ...

Iovance is focusing on the commercialization ... And as you know we manufacture MTAGVI in The U. S. In Philadelphia and most of the raw materials come from The U. S. So the impact on tariffs ...

Iovance Biotherapeutics ... Moreover, the company’s state-of-the-art manufacturing facility in Philadelphia also ensures efficiency in the production of TIL therapies. This is great as it ...